Dead on arrival: understanding the failure of CTLA4-immunoglobulin therapy in inflammatory bowel disease
Gastroenterology
.
2012 Jul;143(1):13-7.
doi: 10.1053/j.gastro.2012.05.015.
Epub 2012 May 21.
Authors
Lloyd Mayer
,
Arthur Kaser
,
Richard S Blumberg
PMID:
22626501
PMCID:
PMC3392152
DOI:
10.1053/j.gastro.2012.05.015
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Colitis, Ulcerative / drug therapy*
Crohn Disease / drug therapy*
Female
Humans
Male
Grants and funding
R37 DK044319/DK/NIDDK NIH HHS/United States
R01 DK088199/DK/NIDDK NIH HHS/United States
R01 DK051362/DK/NIDDK NIH HHS/United States
R01 DK053056/DK/NIDDK NIH HHS/United States
U19 AI044236/AI/NIAID NIH HHS/United States
DK072201/DK/NIDDK NIH HHS/United States
DK086605/DK/NIDDK NIH HHS/United States
DK051362/DK/NIDDK NIH HHS/United States
AI084952/AI/NIAID NIH HHS/United States
DK088199/DK/NIDDK NIH HHS/United States
RC1 DK086605/DK/NIDDK NIH HHS/United States
DK044319/DK/NIDDK NIH HHS/United States
P30 DK034854/DK/NIDDK NIH HHS/United States
R01 AI084952/AI/NIAID NIH HHS/United States
P01 DK072201/DK/NIDDK NIH HHS/United States
AI044236/AI/NIAID NIH HHS/United States
R01 DK044319/DK/NIDDK NIH HHS/United States
P01 AI044236/AI/NIAID NIH HHS/United States
DK053056/DK/NIDDK NIH HHS/United States
R56 DK053056/DK/NIDDK NIH HHS/United States